Understanding how to detect and treat cancer is the best way to eliminate it. That’s why Allegheny Health Network invests resources into finding new ways to fight cancer. We have hundreds of clinical trials investigating the latest approaches to care.
In addition to the clinical trials available through the AHN Cancer Institute, we are able to provide streamlined and guided access to even more clinical trials, thanks to our growing collaboration with the world-renowned Johns Hopkins Medicine. Patients at AHN have streamlined and guided access to the unique expertise of the Johns Hopkins Kimmel Cancer Center team and hundreds of novel therapies through the Center’s clinical trials research program.
You don’t need to travel far from home for sophisticated, pioneering treatment options. AHN patients have local access to many of these revolutionary clinical trials right here in western Pennsylvania. Combined, the two cancer programs have more than 500 active clinical trials, the most in the area.
Together, the AHN Cancer Institute and Johns Hopkins Medicine are working to combat even the rarest and most complex cancers. And AHN patients may benefit from each institution’s ongoing innovation. This includes Johns Hopkins Medicine’s revolutionary proton beam therapy program. It’s a sophisticated, ground-breaking radiation therapy treatment, launching in 2019. Patients may also have access to advanced molecular testing provided by Johns Hopkins Medicine. This technology will help guide more personalized and effective treatment for patients diagnosed with late-stage cancer.
It’s our latest in a long commitment to groundbreaking cancer care. Chief among these discoveries and contributions are: